These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 20556669)

  • 41. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.
    Stan AD; Lewis DA
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1557-62. PubMed ID: 22283765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. l-Proline, GABA Synthesis and Gamma Oscillations in Schizophrenia.
    Volk DW; Gonzalez-Burgos G; Lewis DA
    Trends Neurosci; 2016 Dec; 39(12):797-798. PubMed ID: 27832914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.
    Woo TU; Miller JL; Lewis DA
    Am J Psychiatry; 1997 Jul; 154(7):1013-5. PubMed ID: 9210755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder.
    Benes FM; Berretta S
    Neuropsychopharmacology; 2001 Jul; 25(1):1-27. PubMed ID: 11377916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What an archaeological dig can tell us about macro- and microcircuitry in brains of schizophrenia subjects.
    Benes FM
    Schizophr Bull; 1997; 23(3):503-7. PubMed ID: 9327512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oscillatory, Computational, and Behavioral Evidence for Impaired GABAergic Inhibition in Schizophrenia.
    Shaw AD; Knight L; Freeman TCA; Williams GM; Moran RJ; Friston KJ; Walters JTR; Singh KD
    Schizophr Bull; 2020 Feb; 46(2):345-353. PubMed ID: 31219602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
    Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
    Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered GABAA,slow inhibition and network oscillations in mice lacking the GABAA receptor beta3 subunit.
    Hentschke H; Benkwitz C; Banks MI; Perkins MG; Homanics GE; Pearce RA
    J Neurophysiol; 2009 Dec; 102(6):3643-55. PubMed ID: 19846622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
    Gluck MR; Thomas RG; Davis KL; Haroutunian V
    Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia.
    Daskalakis ZJ; Fitzgerald PB; Christensen BK
    Brain Res Rev; 2007 Dec; 56(2):427-42. PubMed ID: 17980435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer's disease pathology.
    Ahnaou A; Moechars D; Raeymaekers L; Biermans R; Manyakov NV; Bottelbergs A; Wintmolders C; Van Kolen K; Van De Casteele T; Kemp JA; Drinkenburg WH
    Sci Rep; 2017 Oct; 7(1):14189. PubMed ID: 29079799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synchronous oscillatory activity in immature cortical network is driven by GABAergic preplate neurons.
    Voigt T; Opitz T; de Lima AD
    J Neurosci; 2001 Nov; 21(22):8895-905. PubMed ID: 11698601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.
    Lewis DA; Moghaddam B
    Arch Neurol; 2006 Oct; 63(10):1372-6. PubMed ID: 17030651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.
    Hashimoto T; Bazmi HH; Mirnics K; Wu Q; Sampson AR; Lewis DA
    Am J Psychiatry; 2008 Apr; 165(4):479-89. PubMed ID: 18281411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia.
    Volk DW; Lewis DA
    Schizophr Bull; 2014 Sep; 40(5):952-7. PubMed ID: 25053651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
    Volk D; Austin M; Pierri J; Sampson A; Lewis D
    Am J Psychiatry; 2001 Feb; 158(2):256-65. PubMed ID: 11156808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fiber pathway pathology, synapse loss and decline of cortical function in schizophrenia.
    Bennett MR; Farnell L; Gibson WG
    PLoS One; 2013; 8(4):e60518. PubMed ID: 23593232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.
    Lewis DA; Hashimoto T; Morris HM
    Neurotox Res; 2008 Oct; 14(2-3):237-48. PubMed ID: 19073429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Errant ensembles: dysfunctional neuronal network dynamics in schizophrenia.
    Jones MW
    Biochem Soc Trans; 2010 Apr; 38(2):516-21. PubMed ID: 20298213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
    Lewis DA; Volk DW; Hashimoto T
    Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.